Oral tolerization as a treatment of rheumatoid arthritis

Rheumatic Disease Clinics of North America

Volumn 24, Issue 3, 1998, Pages 525-536

  Trentham, D E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COLLAGEN TYPE 2;

IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0031717447     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70024-7     Document Type: Article

References (41)

1. M.L. Barnett D. Combitchi D.E. Trentham A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis Arthritis Rheum 39 1996 623
2. M.L. Barnett J.M. Kremer St Clair E.W. Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial Arthritis Rheum 41 1998 290
3. Boissier M.-C. G. Chiocchia Ronziere M.-C. Arthritogenicity of minor cartilage collagens (types IX and XI) in mice Arthritis Rheum 33 1990 1
4. R.E. Burgerson D.W. Hollister Collagen heterogeneity in human cartilage: Identification of several new collagen chains Biochem Biophys Res Commun 87 1979 1124
5. Y. Chen V.K. Kuchroo Inobe J.-I. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalitis Science 265 1994 1237
6. A.D. Cook M.J. Rowley I.R. Mackay Antibodies to type II collagen in early rheumatoid arthritis: Correlation with disease progression Arthritis Rheum 39 1996 1720
7. A. Dessen C.M. Lawrence S. Cupo X-ray crystal structure of HLA-DR4(DRA*0101, DRB1*0401) complexed with a peptide from human collagen II Immunity 7 1997 473
8. M.C. Doran N.J. Goodstone R.N. Hobbs Cellular immunity to cartilage link protein in patients with inflammatory arthritis and non-arthritis controls Ann Rheum Dis 54 1995 466
9. Eyre D.R. Wu J.-J. L.H. Ericsson Collagen type IX: Evidence for covalent linkages to type II collagen in cartilage FEBS Lett 220 1987 337
10. A. Friedman H.L. Weiner Induction of anergy or active suppression following oral tolerance is determined by antigen dosage Proc Natl Acad Sci U S A 91 1994 6688
11. P. Garside M. Steel E.A. Worthey T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction J Immunol 154 1995 5649
12. T.T. Glant K. Mikecz A. Arzoumanian Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology Arthritis Rheum 30 1987 201
13. A. Guerassimov N. Delaunay S. Banerjee Immunity to cartilage link protein can induce an erosive polyarthritis in BALB/c mice Arthritis Rheum 37 suppl 1994 397
14. S.J. Khoury W.W. Hancock H.L. Weiner Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin-4, and prostaglandin expression in the brain J Exp Med 176 1992 1355
15. S.J. Khoury O. Lider A. Al-Sabbagh Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide Cell Immunol 131 1990 302
16. Leroux J.-Y. A. Guerassimov A. Cartman Immunity to the GI globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratin sulfate in vitro and in vivo J Clin Invest 97 1996 621
17. R.S. Liblau S.M. Singer H.O. McDevitt Th1 and Th2 CD4+ T cells in the pathogenesis of organ specific autoimmune diseases Immunol Today 16 1995 34
18. M. Londei C.M. Savill A. Verhoeh Persistence of collagen type II-specific T cell clones in the synovial membrane of a patient with rheumatoid arthritis Proc Natl Acad Sci U S A 86 1989 636
19. J.G. Michael The role of digestive enzymes in orally induced immune tolerance Immunol Invest 18 1989 1049
20. A. Miller O. Lider H.L. Weiner Antigen-driven bystander suppression after oral administration of antigens J Exp Med 174 1991 791
21. K. Morgan R.B. Clague I. Collins A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis Arthritis Rheum 32 1989 139
22. K. Morgan R.B. Clague I. Collins Incidence of antibodies to native and denatured cartilage collagen (types II, IX and XI) and to type I collagen in rheumatoid arthritis Ann Rheum Dis 46 1987 902
23. K. Morgan H.B. Evans S.A. Firth 1α2α3α collagen is arthritogenic Ann Rheum Dis 42 1983 680
24. A. Mowat The regulation of the immune responses to dietary protein antigens Immunol Today 8 1987 93
25. C. Nagler-Anderson L.A. Bober M.E. Robinson Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen Proc Natl Acad Sci U S A 83 1986 7443
26. G.S. Panayi J.S. Lanchbury G.H. Kingsley The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis [editorial] Arthritis Rheum 35 1992 729
27. S. Ricard-Blum J. Tiollier R. Garrone Further biochemical and physiochemical characterization of minor disulfide-bonded (type IX) collagen, extracted from fetal calf cartilage J Cell Biochem 27 1985 147
28. K.L. Sewell D.E. Trentham Pathogenesis of rheumatoid arthritis Lancet 341 1993 283
29. J. Sieper S. Kary H. Sörenson Oral type II collagen treatment in early rheumatoid arthritis: A double-blind, placebo-controlled, randomized trial Arthritis Rheum 39 1996 41
30. J. Sieper A.N. Mitchison Therapy with oral collagen type II as a new possibility for selective immunosuppression in the therapy of rheumatoid arthritis Z Rheumatol 53 1994 53
31. K. Terato Y. Shimozuru K. Katayama Specificity of antibodies to type II collagen in rheumatoid arthritis Arthritis Rheum 33 1990 1493
32. H.S.G. Thompson N.A. Staines Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats Clin Exp Immunol 64 1986 581
33. D.E. Trentham R.A. Dynesius-Trentham E.J. Orav Effects of oral administration of type II collagen on rheumatoid arthritis Science 261 1993 1727
34. D.E. Trentham A.S. Townes A.H. Kang Autoimmunity to type II collagen: An experimental model of arthritis J Exp Med 146 1977 857
35. H.L. Weiner A. Friedman A. Miller Oral Tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens Annu Rev Immunol 12 1994 809
36. G.F.M. Verheijden A.W.M. Rijinders E. Bos Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis Arthritis Rheum 40 1997 1115
37. C.C. Whitacre I.E. Gienapp C.G. Orosz Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy J Immunol 147 1991 2155
38. B.P. Wordsworth J.S.S. Lanchbury L.I. Sakkas HLA DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region Proc Natl Acad Sci U S A 86 1989 10049
39. S. Yoshino E. Quattrocchi H.L. Weiner Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen Arthritis Rheum 38 1995 1092
40. Z.J. Zhang C.S.Y. Lee O. Lider Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen J Immunol 145 1990 2489
41. Z. Zhang J.G. Michael Orally inducible immune responsiveness is abrogated by IFNγ treatment J Immunol 144 1990 4163